4-{[(2-methylbutan-2-yl)amino]methyl}benzonitrile

Catalog No.: 
ACOBMW308
CAS No.: 
1019595-80-2
Molecular Formula: 
C13H18N2
Molecular Weight: 
202.30
4-{[(2-methylbutan-2-yl)amino]methyl}benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$262.00InquiryInquiry
5g95%$762.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-{[(2-methylbutan-2-yl)amino]methyl}benzonitrile
IUPAC Name4-((tert-pentylamino)methyl)benzonitrile
MDL No.MFCD11138830
Molecular FormulaC13H18N2
Molecular Weight202.30
SMILESN#CC1=CC=C(CNC(CC)(C)C)C=C1
InChI KeyNAQWTQOVEZTTST-UHFFFAOYSA-N
SynonymBenzonitrile, 4-[[(1,1-dimethylpropyl)amino]methyl]-
CAS No.1019595-80-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACOBMW308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCOBN524 route compound structure diagram
    ACCOBN524594-39-8In Stock
  2. Plus
  3. ACAJMV029 route compound structure diagram
    ACAJMV029105-07-7In Stock
  4. Then
  5. ACOBMW308 route product structure diagram
    ACOBMW3081019595-80-2
Inquiry

2. ACOBMW308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCOBN524 route compound structure diagram
    ACCOBN524594-39-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOBMW308 route product structure diagram
    ACOBMW3081019595-80-2
Inquiry

3. ACOBMW308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCOBN524 route compound structure diagram
    ACCOBN524594-39-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOBMW308 route product structure diagram
    ACOBMW3081019595-80-2
Inquiry

Comments (0)